Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SillaJen Inc (215600 KS)
Watchlist
52
Analysis
Health Care
•
South Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Celltrion Inc
•
03 Feb 2021 14:26
Korea Short Sell Ban: Elections, Public Outrage, Bus Tours, Blue House Petitions, K-Streetbets
With the short sell ban in Korea scheduled to expire 15 March, we look at stocks that have seen the most short covering since the start of the ban,...
Brian Freitas
Follow
655 Views
Share
bullish
•
Sangsangin Co., Ltd.
•
27 May 2020 18:53
KOSDAQ150 Index Review - Let's Not Follow The Index Methodology
The KRX announced the list of inclusions and exclusions to the KOSDAQ150 Index today. The rebalance is effective as of 12 June and all passive...
Brian Freitas
Follow
700 Views
Share
bullish
•
Quantitative Analysis
•
15 Apr 2020 05:39
Biotech & Pharma Moving Up As Short Covering Continues
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 10 April 2020, the...
Brian Freitas
Follow
547 Views
Share
bearish
•
Quantitative Analysis
•
04 Feb 2020 17:39
Korea - Shorts Build Positions in Amore Corp, Samsung Elec, HLB, KMW, SillaJen
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 31 January...
Brian Freitas
Follow
508 Views
Share
bullish
•
Quantitative Analysis
•
29 Jan 2020 17:47
Korea - Pharma Stocks See Short Covering
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 23 January...
Brian Freitas
Follow
572 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x